Sign Up to like & get
recommendations!
2
Published in 2023 at "Therapeutics and Clinical Risk Management"
DOI: 10.2147/tcrm.s389694
Abstract: Introduction Non-high-density-lipoprotein cholesterol (non-HDL-C) is a secondary therapeutic target in cardiovascular diseases and is used for residual risk assessment in patients with coronary artery syndrome (ACS). This study was designed to determine the association between…
read more here.
Keywords:
cabg acs;
prior cabg;
patients prior;
non hdl ... See more keywords